Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Highly Accessed Research article

Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells

Liza Konnikova, Maciej Kotecki, Mathew M Kruger and Brent H Cochran*

Author Affiliations

Department of Physiology, Tufts University School of Medicine 136 Harrison Ave., Boston, Massachusetts, 02111, USA

For all author emails, please log on.

BMC Cancer 2003, 3:23  doi:10.1186/1471-2407-3-23

Published: 17 September 2003



Astrocytomas are the most common type of primary central nervous system tumors. They are frequently associated with genetic mutations that deregulate cell cycle and render these tumors resistant to apoptosis. STAT3,

ransducer and
ctivator of
ranscription 3, participates in several human cancers by inducing cell proliferation and inhibiting apoptosis and is frequently activated in astrocytomas.


RNA interference was used to knockdown STAT3 expression in human astrocytes and astrocytoma cell lines. The effect of STAT3 knockdown on apoptosis, cell proliferation, and gene expression was then assessed by standard methods.


We have found that STAT3 is constitutively activated in several human astrocytoma cell lines. Knockdown of STAT3 expression by siRNA induces morphologic and biochemical changes consistent with apoptosis in several astrocytoma cell lines, but not in primary human astrocytes. Moreover, STAT3 is required for the expression of the antiapoptotic genes survivin and Bcl-xL in the A172 glioblastoma cell line.


These results show that STAT3 is required for the survival of some astrocytomas. These studies suggest STAT3 siRNA could be a useful therapeutic agent for the treatment of astrocytomas.